Objectives: To analyse the ongoing epidemiology of KPC-producing Enterobacteriaceae after a non-ST258 KPC-3-producing Klebsiella pneumoniae outbreak in a university hospital in Madrid, Spain.
Introduction
Genes coding for KPC enzymes are predominantly identified among Klebsiella pneumoniae isolates and, increasingly, among other Enterobacteriaceae and in Pseudomonas spp. and Acinetobacter baumannii.
1 Until recently, the global predominance of KPC-producing K. pneumoniae was associated with clonal group (CG) 258, compromising the globally spread sequence type (ST) 258, and a diversity of single-and double-locus variants including ST11. 1, 2 Other widespread (e.g. ST437) and local STs have been sporadically identified in areas with a high prevalence of KPC isolates. 3 These data indicate that bla KPC genes have a potentially high risk of dissemination among different clones and species. 4 -6 We previously described the emergence of KPC-3-producing K. pneumoniae in Spain that was not associated with CG258 clones. 7 During a 5 month period (September 2009 to February 2010), KPC-3-producing ST384 and ST388 K. pneumoniae clones were recovered from seven and one patient, respectively, in different hospital wards. 7 In this study, we describe the ongoing epidemiology of KPC-producing Enterobacteriaceae in our institution, showing the dissemination of KPC enzymes in different K. pneumoniae, Escherichia coli and Enterobacter cloacae clones.
Methods
Bacterial isolates and study design From 16 March 2010 through 31 January 2012, a total of 98 Enterobacteriaceae isolates with decreased carbapenem susceptibility according to the EUCAST epidemiological cut-off values (www.eucast.org), a positive modified Hodge test (MHT) and carbapenem/boronic acid combination disc test result were recovered from 23 patients. Clinical records of infected or colonized patients were retrospectively reviewed. Infection control measures were implemented after the detection of each new case as previously described. 7 Surveillance samples (rectal, pharyngeal and wound swabs) were plated on chromID ESBL agar (bioMérieux, Marcy l'Étoile, France). Growing colonies were sought for carbapenemase production. 7 
Bacterial identification and antibiotic susceptibility testing
Bacterial identification was performed with a matrix-assisted laser desorption ionization-time of flight mass spectrometry method (Bruker Daltonics GmbH, Leipzig, Germany). Antibiotic susceptibility was determined by standard microdilution and Etest (bioMérieux), and interpreted according to EUCAST criteria. The screening for carbapenemase production included the MHT and combined-disc test using meropenem plus boronic acid or EDTA. 7 Extended-spectrum b-lactamase (ESBL) production was screened by double-disc synergy testing. 7 
Characterization of antibiotic resistance genes
Characterization of genes encoding carbapenemases (bla KPC , bla VIM , bla NDM and bla OXA-48 ) and ESBLs (bla TEM , bla SHV and bla CTX-M ) was carried out by PCR and sequencing. 7, 8 qnr genes were sought by multiplex PCR.
7
Transferability of bla KPC and plasmid characterization
The transfer of KPC plasmids was assessed by filter mating using E. coli K-12 BM21 as the recipient. 7 Transconjugants were selected on Luria-Bertani agar plates containing imipenem (0.5 mg/L), ceftazidime (2 mg/L) and rifampicin (100 mg/L). Plasmid DNA was extracted using a modified alkalinelysis protocol, 7 and the incompatibility group was determined using the PCR-based replicon typing scheme. 9 The size of the KPC plasmids and the association with replicon type were confirmed by hybridization of S1 nuclease-digested genomic DNA from E. coli transconjugants (or wild-type strains in the absence of transfer) with appropriate probes. 10 Similarity between the KPC plasmids was assessed by comparing EcoRI-, PstI-and HpaI-digested plasmid DNA profiles in all transconjugants. 7 
Clonal relatedness
Isolates were typed by PFGE of XbaI-digested DNA. 7 K. pneumoniae and E. coli isolates were also characterized by multilocus sequence typing (MLST) (see http://www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html and http://mlst.ucc.ie/mlst/dbs/Ecoli).
Results

Patients and bacterial isolates
Twenty-three patients were infected and/or colonized by KPCproducing Enterobacteriaceae isolates. The patients were mostly elderly (median age 72 years, range 24 -86 years) with multiple underlying illnesses (Table 1) . Infection was documented in eight cases, the most prevalent being intra-abdominal infection (Table 1) . Nineteen patients were admitted to different wards and had a prolonged hospital stay (median 38 days, range 16 -152 days). The median number of days between admission and the first positive culture with KPC-producing isolates was 23 (range 9 -70 days). In the case of the remaining four patients, three were attended in the emergency room and one was an outpatient at the time of collection of the first positive sample. All of them had had a previous recent hospitalization in our institution. None of the patients had travelled abroad or been transferred from another hospital.
Overall, 98 KPC-producing Enterobacteriaceae isolates were identified (79 K. pneumoniae, 16 E. coli and 3 E. cloacae). In 15 patients, isolates were recovered either from multiple sites or consecutively from different samples. K. pneumoniae isolates were recovered from 20 patients either from clinical (n¼ 15) or surveillance samples (n¼ 64), while E. coli and E. cloacae were isolated only from surveillance sampling sites (n¼19).
All Enterobacteriaceae consecutively recovered from the same patient exhibited indistinguishable PFGE profiles. Consequently, 24 enterobacterial isolates (20 K. pneumoniae, 2 E. coli and 2 E. cloacae) corresponding to the first isolate of each clone identified per patient were selected for further molecular studies.
Antimicrobial susceptibility and phenotypic carbapenemase detection
All isolates were resistant to penicillin/inhibitor combinations, extended-spectrum cephalosporins and aztreonam, but were susceptible to amikacin and colistin (MIC ,2 mg/L) ( Table 2 The MHT and the carbapenem/boronic acid combination disc test were positive for all isolates. The disc diffusion assay with EDTA was negative, as was that for ESBL detection.
Clonal relatedness and distribution over time
XbaI-PFGE identified six pulsotypes of K. pneumoniae, two of E. coli and one of E. cloacae (Table 2) . MLST demonstrated that each K. pneumoniae PFGE type was associated with a different ST (ST11, ST20, ST384, ST454, ST659 and ST971). K. pneumoniae (Kpn)-A/ST384 and Kpn-G/ST659 (six isolates each) were the most frequently detected clones, followed by Kpn-F/ST454 (four isolates). With the exception of ST11, a single-locus variant of ST258, none of the K. pneumoniae belonged to the CG258 group.
The distribution of KPC-producing clones over time since the first detection of KPC in our institution in September 2009 is shown in Figure S1 (available as Supplementary data at JAC Online). Only three K. pneumoniae clones (Kpn-A/ST384, Kpn-F/ST454 and 
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Kpn-G/ST659) were found during more than a 1 month period, while other clones were only occasionally detected.
Molecular characterization of antibiotic resistance genes and plasmids
The presence of bla KPC-3 was demonstrated in five K. pneumoniae and in one E. coli clone (Eco-I/ST357) ( Table 2 ). The remaining K. pneumoniae (Kpn-E/ST20), E. coli (Eco-C/ST224) and E. cloacae (Eclo-H) clones harboured bla KPC-2 . None of the clones harboured bla ESBL , other bla carbapenemase or qnr genes. The bla KPC-3 gene was only transferable for isolates belonging to three K. pneumoniae clones (Kpn-F/ST454, Kpn-G/ST659 and Kpn-J/ST971) and one E. coli clone (Eco-I/ST357). In these clones, bla KPC-3 was located on an 100 kb plasmid showing a highly similar restriction fragment length polymorphism (RFLP) pattern in all transconjugants ( Table 2 ). The nucleotide sequence of these replicons was 99% identical to those of pKpQIL-ITand pKpQIL plasmids (GenBank accession numbers JN233705 and GU595196), which belong to the FII K group. This plasmid was identified in one K. pneumoniae clone (Kpn-G/ST659) and one E. coli clone (Eco-I/ ST357), which were sequentially recovered in the same patient (Table 2) . On the other hand, bla KPC-3 was located on nontransferable 100 kb IncFII K and 40 kb IncN plasmids in Kpn-A/ST384 and Kpn-D/ST11 clones, respectively. The bla KPC-2 gene was associated with non-typeable and non-transferable 20 kb plasmids ( Table 2 ).
Discussion
The epidemiology of KPC producers has been mainly associated with the global expansion of multidrug-resistant K. pneumoniae ST258 and the dissemination of plasmids of different incompatibility groups. 3, 4 The most remarkable finding from our local epidemiology is that the most prevalent KPC-K. pneumoniae clones (ST384, ST454 and ST659) have not been previously linked with KPC production and are not clustered with any of the high-risk clones previously associated with these enzymes. 3 In the USA and Israel, where KPC K. pneumoniae ST258 is already endemic, the later dissemination of bla KPC genes was also associated with non-epidemic genetic lineages. 5, 6 In Spain, the prevalence of KPC is still low since most of the carbapenemases identified are VIM and more recently OXA-48. 2, 11 In this scenario, bla KPC-3 genes emerged in genetic lineages that were probably circulating as part of our local clonal pool. This was in fact the case for Kpn-ST388, which was found in 2009 in our hospital carrying bla KPC-3 and bla CTX-M-10 , but had been present since 1998 only carrying bla CTX-M-10 . 7 However, we occasionally found ST11, a single-locus variant of ST258, which is also a worldwidespread clone, but linked to different predominant b-lactamase genes such as bla CTX-M-14 , bla CTX-M-15 , bla KPC-2 , bla VIM , bla NDM and, recently, bla OXA-48 . 2,4,12 -14 In our institution, ST11 was not associated with either ESBL or VIM producers prior to the detection of KPC producers, but it has been responsible for the emergence of isolates carrying bla OXA-48 during 2012 (D. Gijó n, unpublished results). These observations suggest that the spread of the so-called high-risk clones might be constrained by the local populations of K. pneumoniae. Cases are numbered in chronological order. In Case 13, the patient was infected by a KPC-3-producing K. pneumoniae and simultaneously colonized by a KPC-3-producing K. pneumoniae and a KPC-3-producing E. coli. ICU, intensive care unit; LOS, length of stay.
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In addition to the successful clones, previous studies have demonstrated that the spread of KPC genes is also linked to Tn4401 and different types of transferable IncF(k), IncL/M and IncX plasmids. 4, 12, 15 We reported the recovery of conjugative 100 kb IncFII k plasmids exhibiting the same RFLP pattern from K. pneumoniae and E. coli clones. IncFII k plasmids have greatly contributed to the spread of antibiotic resistance genes such as bla CTX-M-15 or bla KPC among K. pneumoniae, but they also have the ability to transfer between other enterobacterial species. 16, 17 bla KPC -harbouring IncFII k plasmids have been mainly described in K. pneumoniae ST258 in different countries including Israel, Italy, Poland, Greece and the USA. 12,17 -19 The results of our work demonstrated, as in other studies, that IncFII k plasmids harbouring bla KPC genes were not restricted to ST258 clones. 12, 17 Although the in vitro conjugative efficiency of this IncFII k plasmid was low (data not shown), we identified the same plasmid in a K. pneumoniae (Kpn-G/ST659) and in an E. coli (Eco-I/ST357) clone sequentially recovered from the same patient, suggesting an in vivo plasmid transfer. This phenomenon has previously been reported involving the transfer of a KPC-3-encoding IncFII k plasmid from K. pneumoniae ST258 to E. coli, which might act as an accidental recipient present in patients' microbiota. 20 In this sense, the intestinal tract of colonized patients might play an important role in the clonal dissemination and horizontal transfer of genetic platforms between multiple K. pneumoniae clones (not only ST258) and other species, thus favouring the ecological adaptation and persistence of KPCgenes in the hospital and the surrounding nosocomial environment.
In summary, we have described the rapid penetration of bla KPC genes to different unrelated K. pneumoniae clones in the absence of the classic epidemic K. pneumoniae ST258 high-risk clone. These findings highlight the importance of horizontal gene transfer in the dissemination of bla KPC genes and the role of the local clonal pool as potential substrate for the acquisition of these genes. 
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